title: Acquired hemophilia, rheumatoid arthritis, and TNFα antagonists: Comment on the article "Acquired hemophilia possibly induced by etanercept in a patient with rheumatoid arthritis" by Banse et al., Joint Bone Spine 2015;82:200-2.
authors.affiliation: Service de rhumatologie, CHRU de Besançon, 3, boulevard Fleming, 25030 Besançon, France.
authors.forename: Anne
authors.initials: A
authors.lastname: Brinster
authors.affiliation: Centre régional de traitement de l'hémophilie, consultation d'hémostase, CHRU de Besançon, Besançon, France.
authors.forename: Marie Anne
authors.initials: MA
authors.lastname: Bertrand
authors.affiliation: Service de rhumatologie, CHRU de Besançon, 3, boulevard Fleming, 25030 Besançon, France.
authors.forename: Xavier
authors.initials: X
authors.lastname: Guillot
authors.affiliation: Service de rhumatologie, CHRU de Besançon, 3, boulevard Fleming, 25030 Besançon, France.
authors.forename: Maxime
authors.initials: M
authors.lastname: Sondag
authors.affiliation: Service de rhumatologie, CHRU de Besançon, 3, boulevard Fleming, 25030 Besançon, France. Electronic address: dwendling@chu-besancon.fr.
authors.forename: Daniel
authors.initials: D
authors.lastname: Wendling
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D000068800:Etanercept / Q000009:adverse effects*; D005260:Female; D006467:Hemophilia A / Q000139:chemically induced*; D006801:Humans
chemical_list: D018501:Antirheumatic Agents; D000068800:Etanercept
keywords: Acquired hemophilia; Rheumatoid arthritis; TNFα antagonist therapy